24/06/2021 Dementias Platform UK report reveals multiple impacts of COVID-19 pandemic on dementia research COVID-19 situation
23/06/2021 Eisai and Biogen have been granted US FDA Grants Breakthrough Therapy designation for lecanemab in AD Science watch
22/06/2021 EU Parliament and Council reach political agreement on the Health Technology Assessment Regulation EU developments
21/06/2021 EU-FINGERS and LETHE launch survey to collect views on early diagnosis and prevention of Alzheimer’s disease EU projects
21/06/2021 Dementia Lithuania forms partnership with Lithuanian Sports University Dementia in society
21/06/2021 Innovative Medicines Initiative publishes videos from its “Impact on dementia” event EU projects
21/06/2021 Results from the DIAN-TU trial show that gantenerumab reduces key biomarkers in inherited form of Alzheimer’s disease Science watch
21/06/2021 The eye as a window to the brain: RECOGNISED convenes an online General Assembly meeting EU projects
18/06/2021 Analysis of UK ONS data shows that communities with a high density of care homes and residential overcrowding experienced higher excess mortality during the COVID-19 pandemic COVID-19 situation
17/06/2021 Sponsors and members discuss developments in clinical trials, EU policy, HorizonEurope and EU framework for health technology assessments, at our online company roundtable Alzheimer Europe
